BACKGROUND OF THE INVENTION

I have invented a new and novel tuberculosis medication. My improved medication can treat tuberculosis of the pulmonary system glandular system bones and the intestines. Further, this improved medication is of particular value in its ability to kill the tubercle baccillus directly and to dissolve caseation of the focus, thereby producing a radical treatment with no side effects in the patients. The medication has been used at various treatment rates and at various times during research done over several years and has established a successful cure record.

Prior art references known at the time of preparation of this application include the following U.S. Pat. Nos. 1,903,614, 1,889,195, 1,435,335, 87,603, 308,596, and 112,329.

BRIEF DESCRIPTION OF THE INVENTION

My improved tuberculosis medication utilizes a portion of calcium gluconate combined with a portion of sodium iodine by mixing to which distilled water is added to form a product a portion of which is used for the individual treatments by injection either intravenously or intramuscularly .

BRIEF DESCRIPTION OF THE FIGURES

My invention can be understood in view of the accompanying figure.

FIG. 1 is a schematic diagram showing the preparation and use of the medication formulation.

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT

With regard to FIG. 1, 10 grams of calcium gluconate 10 can be combined with 4 grams of sodium iodine 12 by mixing 14 and distilled water 16 can be added to the mixture 14 to a volumn of 100 ccs 16 in order to produce a product 18 which can be used 20 in 5 or 10 cc intravenous or intramuscular injections 20 for treatment of the individual patient.

Having described a preferred embodiment of my invention, it is understood that various changes can be made without departing from the spirit of my invention, and, I desire to cover by the appended claims all such modifications as fall within the true spirit and scope of my invention.